Dupilumab in a patient with severe asthma and glucocorticoid hypersensitivity: a case report

Recently, several biologics have been approved for the treatment of severe asthma. Dupilumab, a biologic used to treat severe asthma, is a monoclonal antibody targeting interleukin-4 and interleukin-13. In the present case, inhaled corticosteroid-induced glucocorticoid hypersensitivity was suspected...

Descripción completa

Detalles Bibliográficos
Autores principales: Handa, Hiroshi, Tsuruoka, Hajime, Kinoshita, Kohei, Mineshita, Masamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467398/
https://www.ncbi.nlm.nih.gov/pubmed/37607026
http://dx.doi.org/10.1177/03000605231193922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467398/
https://www.ncbi.nlm.nih.gov/pubmed/37607026
http://dx.doi.org/10.1177/03000605231193922

Ejemplares similares